Our findings demonstrated that the CP-PTX-Poly IC nanoparticles exhibited efficient cellular uptake across different cancer types, including breast cancer (4T1), liver cancer (HepG2), and pancreatic cancer (Pan02). This evidence concerns the gene CP and liver cancer.